[{"address1": "200 Minuteman Road", "address2": "Suite 302", "city": "Andover", "state": "MA", "zip": "01810", "country": "United States", "phone": "978 552 0900", "website": "https://www.transmedics.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.", "fullTimeEmployees": 728, "companyOfficers": [{"maxAge": 1, "name": "Dr. Waleed H. Hassanein M.D.", "age": 56, "title": "Founder, President, CEO & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 2102712, "exercisedValue": 24642728, "unexercisedValue": 27628236}, {"maxAge": 1, "name": "Mr. Gerardo  Hernandez", "age": 53, "title": "CFO & Treasurer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 214619, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nicholas  Corcoran", "age": 41, "title": "Senior Vice President of Supply Chain & Operations", "yearBorn": 1983, "fiscalYear": 2024, "totalPay": 826904, "exercisedValue": 1062782, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Anil  Ranganath", "age": 43, "title": "Senior VP, General Counsel & Corporate Secretary", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 594250, "exercisedValue": 222899, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tamer I. Khayal M.D.", "age": 55, "title": "Chief Commercial Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 1066281, "exercisedValue": 10194814, "unexercisedValue": 122830}, {"maxAge": 1, "name": "Ms. Miriam C. Provost Ph.D.", "age": 63, "title": "Vice President of Global Regulatory Affairs", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 535930, "exercisedValue": 390248, "unexercisedValue": 1664774}], "auditRisk": 4, "boardRisk": 3, "compensationRisk": 6, "shareHolderRightsRisk": 3, "overallRisk": 4, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 95.81, "open": 96.94, "dayLow": 94.205, "dayHigh": 98.5, "regularMarketPreviousClose": 95.81, "regularMarketOpen": 96.94, "regularMarketDayLow": 94.205, "regularMarketDayHigh": 98.5, "payoutRatio": 0.0, "beta": 1.901, "trailingPE": 90.01803, "forwardPE": 58.37533, "volume": 841283, "regularMarketVolume": 841283, "averageVolume": 1136731, "averageVolume10days": 892450, "averageDailyVolume10Day": 892450, "bid": 70.92, "ask": 96.92, "bidSize": 2, "askSize": 1, "marketCap": 3258279680, "fiftyTwoWeekLow": 55.0, "fiftyTwoWeekHigh": 177.37, "priceToSalesTrailing12Months": 7.3793535, "fiftyDayAverage": 77.0136, "twoHundredDayAverage": 100.39227, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 3406828032, "profitMargins": 0.08031999, "floatShares": 32671006, "sharesOutstanding": 33827900, "sharesShort": 8782313, "sharesShortPriorMonth": 9551242, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.25959998, "heldPercentInsiders": 0.02992, "heldPercentInstitutions": 1.1159999, "shortRatio": 8.35, "shortPercentOfFloat": 0.4486, "impliedSharesOutstanding": 33827900, "bookValue": 6.8, "priceToBook": 14.164602, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "earningsQuarterlyGrowth": 0.701, "netIncomeToCommon": 35464000, "trailingEps": 1.07, "forwardEps": 1.65, "enterpriseToRevenue": 7.716, "enterpriseToEbitda": 59.504, "52WeekChange": -0.25596023, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 96.3193, "targetHighPrice": 125.0, "targetLowPrice": 80.0, "targetMeanPrice": 105.28571, "targetMedianPrice": 105.0, "recommendationMean": 1.77778, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 336649984, "totalCashPerShare": 10.001, "ebitda": 57254000, "totalDebt": 518287008, "quickRatio": 7.25, "currentRatio": 8.299, "totalRevenue": 441540000, "debtToEquity": 226.719, "revenuePerShare": 13.287, "returnOnAssets": 0.031040002, "returnOnEquity": 0.19389999, "grossProfits": 262080992, "freeCashflow": -102769624, "operatingCashflow": 48803000, "earningsGrowth": 0.769, "revenueGrowth": 0.498, "grossMargins": 0.59356, "ebitdaMargins": 0.12967, "operatingMargins": 0.07107, "financialCurrency": "USD", "symbol": "TMDX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1746725289, "exchange": "NGM", "messageBoardId": "finmb_429233", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.5315732, "regularMarketPrice": 96.3193, "longName": "TransMedics Group, Inc.", "shortName": "TransMedics Group, Inc.", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1556803800000, "regularMarketChange": 0.50930023, "marketState": "REGULAR", "regularMarketDayRange": "94.205 - 98.5", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1136731, "fiftyTwoWeekLowChange": 41.319298, "fiftyTwoWeekLowChangePercent": 0.75126, "fiftyTwoWeekRange": "55.0 - 177.37", "fiftyTwoWeekHighChange": -81.0507, "fiftyTwoWeekHighChangePercent": -0.45695832, "fiftyTwoWeekChangePercent": -25.596024, "earningsTimestamp": 1746734400, "earningsTimestampStart": 1746734400, "earningsTimestampEnd": 1746734400, "earningsCallTimestampStart": 1746736200, "earningsCallTimestampEnd": 1746736200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 1.07, "epsForward": 1.65, "epsCurrentYear": 1.50467, "priceEpsCurrentYear": 64.013565, "fiftyDayAverageChange": 19.305695, "fiftyDayAverageChangePercent": 0.25067902, "twoHundredDayAverageChange": -4.072975, "twoHundredDayAverageChangePercent": -0.040570606, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.8 - Buy", "displayName": "TransMedics", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]